About Biosign Technologies
- Biosign Technologies » profile | management
- Biomedical company » factsheet
- Based in Toronto, Ontario » map
- Stock Exchange » CNSX:BIO
Biosign's mission is to help people monitor their health.
As a first step into this mission, Biosign has taken a new approach to health monitoring. Inspired by the classic method of patient consultation, the approach has led to an automated system that takes the pulse and listens to the patient over the Internet.
Trademarked UFIT, the system serves as Biosign's platform for delivering health monitoring services to individuals around the world. All services, including blood pressure monitoring, rely on digital representations of your pulse taken at the wrist through an inflatable cuff by a portable device connected to your computer. Stored on Biosign’s data server, these readings inform the MODERN tasks of UFIT monitoring – Measuring, Observing, Detecting, Evaluating, Reporting, and Networking.
This interactive, service oriented architecture allows UFIT to sense and respond to adverse events. For instance, a pulse irregularity may lead you to review your history, read lab and pharmacy records, or search the world for evidence pertinent to your case (clinical studies, trials, guidelines, etc). News about your health may then be fed to your health care "subscribers" (relatives, friends, physicians, etc).
As a business, Biosign seeks profits from work that benefits consumers of health products and services. To that end, Biosign strives to set UFIT as a global health monitor that addresses issues of universal concern, useful to consumers as well as to providers, vendors, employers, regulators, and researchers. Detecting and reporting adverse reactions is such a universal concern and so is the need to reduce the uncertainty and the costs of optimizing "high number" conditions related to blood pressure, blood glucose, and weight.